Abstract
The COVID-19 pandemic has increased the prevalence of chronic health concerns worldwide, leading to a new population of patients suffering from Long Covid. Patients with Long Covid often experience persistent symptoms impacting multiple organ systems, including neuroimmune and neurological manifestations. Recently, attention has grown toward Long Covid patients developing chronic widespread pain similar to fibromyalgia. Fibromyalgia is a nociplastic pain disorder characterized by widespread pain and central sensitization with fatigue, sleep disturbances, and impairments in cognitive functioning. Given the nascent and limited research exploring new treatment options, patients need support now from biopsychosocial multi-modal pain management strategies. The Fibromyalgia Program at Penn Medicine Lancaster General Health offers a biopsychosocial paradigm for increasing access to treatments that emphasize functional improvement and quality of life among patients with Long Covid fibromyalgia.
Recommended Citation
Harrison, Joseph and Given, Dennis Psy.D.
(2024)
"Biopsychosocial Management of Long Covid Fibromyalgia: Lessons from the Penn Medicine Lancaster General Health Fibromyalgia Program,"
The Journal of Integrated Primary Care: Vol. 1:
Iss.
2, Article 2.
Available at:
https://digitalcommons.pcom.edu/jipc/vol1/iss2/2
Included in
Clinical Psychology Commons, Health Psychology Commons, Medicine and Health Sciences Commons, Pain Management Commons
